Navigation Links
Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
Date:5/7/2013

his press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect.  Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  These and other risks concerning Regulus' programs are described in additional detail in Regulus' SEC filings.  All forward-looking statements contained in this press release speak only as of the date on which they were made. Regulus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
2. Regulus to Present at Future Leaders in the Biotech Industry Conference
3. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
4. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
5. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
6. Regulus to Present at Two Upcoming Investor Conferences
7. Regulus Appoints Mark G. Foletta to its Board of Directors
8. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
9. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
10. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
11. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 This report analyzes the worldwide markets ... the following Segments: Standard Intraocular Lenses, and Premium Intraocular Lenses. ... Canada , Japan , ... Latin America , and Rest of World. Annual ... 2020. Also, a seven-year historic analysis is provided for these ...
(Date:5/28/2015)... , May 28, 2015 Isis Pharmaceuticals, ... , Akcea Therapeutics WebcastWhen: , Thursday, June 4 at ... www.isispharm.com How: , Live on the Internet.  Simply log ... to participate during the live event, a replay of ... at www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, ...
(Date:5/28/2015)... 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... at the Jefferies 2015 Healthcare Conference on Wednesday, June ... New York .  Lexicon management will provide ... A webcast of the presentation will be ... archived version of the presentation will be available at ...
Breaking Medicine Technology:World Intraocular Lenses Industry 2World Intraocular Lenses Industry 3World Intraocular Lenses Industry 4World Intraocular Lenses Industry 5World Intraocular Lenses Industry 6World Intraocular Lenses Industry 7World Intraocular Lenses Industry 8World Intraocular Lenses Industry 9World Intraocular Lenses Industry 10World Intraocular Lenses Industry 11World Intraocular Lenses Industry 12World Intraocular Lenses Industry 13World Intraocular Lenses Industry 14World Intraocular Lenses Industry 15World Intraocular Lenses Industry 16World Intraocular Lenses Industry 17World Intraocular Lenses Industry 18World Intraocular Lenses Industry 19World Intraocular Lenses Industry 20World Intraocular Lenses Industry 21World Intraocular Lenses Industry 22World Intraocular Lenses Industry 23World Intraocular Lenses Industry 24World Intraocular Lenses Industry 25World Intraocular Lenses Industry 26Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3Lexicon To Present At The Jefferies 2015 Healthcare Conference 2
... BARCELONA, Spain , June 1 Clinicians at Institut Catala ... in Spain using RapidArc® radiotherapy from Varian Medical Systems (NYSE: ... the first patient in the country to receive the fast and efficient ... "The treatment went ...
... BEIJING , June 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... it has received,the confirmation from the China International Tendering Company that Sinovac,was ... supply the Company,s hepatitis A vaccine, Healive, to the,Beijing Expanded Program of ... ...
Cached Medicine Technology:Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 2Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 3Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 4Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R) 2Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R) 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... “beauty of protection”. Skin Health is a cross-platform ... within the markets of New York, Los Angeles, and ... 750,000 readers. Its digital counterpart will reach a national ... To read more the Skin Health campaign and Colorescience, ...
(Date:5/29/2015)... Dallas, TX (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the therapeutic ... different types of muscles in the body, leading ... strengthens R&D pipelines by identifying new targets and ... report on H1 2015 pipeline review of Axillary ...
(Date:5/29/2015)... Designed with the versatile athlete in mind, BPI ... new, exclusive line of supplementation called The 24/7 Series. ... greatest, high impact, result driven ingredients that have been ... Series can be used by anyone from bodybuilders to ... enthusiasts. There are no stimulant based ingredients that cause ...
(Date:5/29/2015)... The annual aesthetic meeting, put on by ... in Montreal from May 14-19th. This global event sets ... around the world; dedicating itself exclusively to cosmetic medicine. ... plastic surgeons to attend this year’s meeting. , Among ... Vitenas was given the honor of sitting at the presenter’s ...
(Date:5/29/2015)... Dallas, TX (PRWEB) May 29, 2015 ... Pipeline Review, H1 2015” provides comprehensive information ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report on H1 ... 18 market data tables and 13 figures, ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3
... Today AXA Equitable,unveiled its new Athena Survivorship ... to deliver cost-effective death benefit,protection to couples and ... needs. By providing a death benefit upon the ... be used to pay sizeable estate,taxes and other ...
... ... Care, STANFORD, ... have donated $150,000 to Lucile,Packard Children,s Hospital at Stanford to expand clinical ... PI is a term that encompasses more than 150 diseases caused ...
... Boston, MAScientists at Schepens Eye Research Institute have ... of tear production are more likely to develop ... situ keratomileusis), laser refractive surgery to correct near- ... Their research, published in the January issue of ...
... ... Processes, NEW ORLEANS, March 3 ... serving science, today launched,significant new technologies at PITTCON 2008 that are designed ... and,applications. PITTCON, the world,s largest conference and exposition for,laboratory science, is under ...
... the FORTUNE ... Survey, MILWAUKEE, March 3 ... 2008 annual survey, FORTUNE,magazine ranked the company as "America,s Most Admired" in the ... have led its industry every year it has been included in,the prestigious survey ...
... , In humans, as in all mammals, ... alternates with dream phases, called Rapid Eye Movement (REM)-sleep. ... memories are consolidated during sleep, this remains a hotly ... help to clarify the function of sleep by revealing ...
Cached Medicine News:Health News:AXA Equitable Meets the Needs of Two People under One Life Insurance Policy 2Health News:AXA Equitable Meets the Needs of Two People under One Life Insurance Policy 3Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 2Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 3Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 4Health News:Scientists discover who is likely to get dry eye syndrome after LASIK surgery 2Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 2Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 3Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 4Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 5Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 6Health News:Northwestern Mutual Is 'America's Most Admired' for an Unprecedented 25th Year 2Health News:'Power napping' in pigeons 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: